315 related articles for article (PubMed ID: 33588776)
1. MicroRNA-545 suppresses progression of ovarian cancer through mediating PLK1 expression by a direct binding and an indirect regulation involving KDM4B-mediated demethylation.
Zhang H; Zhang K; Xu Z; Chen Z; Wang Q; Wang C; Cui J
BMC Cancer; 2021 Feb; 21(1):163. PubMed ID: 33588776
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of MicroRNA-375 Promoter Methylation in Promoting Ovarian Cancer Cell Malignancy.
Shu J; Xiao L; Yan S; Fan B; Zou X; Yang J
Technol Cancer Res Treat; 2021; 20():1533033820980115. PubMed ID: 33928819
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-139-5p Inhibits Cell Proliferation and Invasion by Targeting RHO-Associated Coiled-Coil-Containing Protein Kinase 2 in Ovarian Cancer.
Wang Y; Li J; Xu C; Zhang X
Oncol Res; 2018 Apr; 26(3):411-420. PubMed ID: 28653604
[TBL] [Abstract][Full Text] [Related]
4. Impact of iASPP on chemoresistance through PLK1 and autophagy in ovarian clear cell carcinoma.
Chan KK; Wong OG; Wong ES; Chan KK; Ip PP; Tse KY; Cheung AN
Int J Cancer; 2018 Sep; 143(6):1456-1469. PubMed ID: 29663364
[TBL] [Abstract][Full Text] [Related]
5. MicroRNA-100 is a potential molecular marker of non-small cell lung cancer and functions as a tumor suppressor by targeting polo-like kinase 1.
Liu J; Lu KH; Liu ZL; Sun M; De W; Wang ZX
BMC Cancer; 2012 Nov; 12():519. PubMed ID: 23151088
[TBL] [Abstract][Full Text] [Related]
6. Misregulation of polo-like protein kinase 1, P53 and P21WAF1 in epithelial ovarian cancer suggests poor prognosis.
Zhang R; Shi H; Ren F; Liu H; Zhang M; Deng Y; Li X
Oncol Rep; 2015 Mar; 33(3):1235-42. PubMed ID: 25592872
[TBL] [Abstract][Full Text] [Related]
7. CircPLK1 sponges miR-296-5p to facilitate triple-negative breast cancer progression.
Kong Y; Yang L; Wei W; Lyu N; Zou Y; Gao G; Ou X; Xie X; Tang H
Epigenomics; 2019 Aug; 11(10):1163-1176. PubMed ID: 31337246
[No Abstract] [Full Text] [Related]
8. STK39 is a novel kinase contributing to the progression of hepatocellular carcinoma by the PLK1/ERK signaling pathway.
Zhang C; Wang X; Fang D; Xu P; Mo X; Hu C; Abdelatty A; Wang M; Xu H; Sun Q; Zhou G; She J; Xia J; Hui KM; Xia H
Theranostics; 2021; 11(5):2108-2122. PubMed ID: 33500714
[No Abstract] [Full Text] [Related]
9. miR-100 resensitizes resistant epithelial ovarian cancer to cisplatin.
Guo P; Xiong X; Zhang S; Peng D
Oncol Rep; 2016 Dec; 36(6):3552-3558. PubMed ID: 27748936
[TBL] [Abstract][Full Text] [Related]
10. lncRNA CCAT1 is a biomarker for the proliferation and drug resistance of esophageal cancer via the miR-143/PLK1/BUBR1 axis.
Hu M; Zhang Q; Tian XH; Wang JL; Niu YX; Li G
Mol Carcinog; 2019 Dec; 58(12):2207-2217. PubMed ID: 31544294
[TBL] [Abstract][Full Text] [Related]
11. TPX2 promotes cell proliferation and migration via PLK1 in OC.
Ma S; Rong X; Gao F; Yang Y; Wei L
Cancer Biomark; 2018; 22(3):443-451. PubMed ID: 29865033
[TBL] [Abstract][Full Text] [Related]
12. MicroRNA-23a depletion promotes apoptosis of ovarian cancer stem cell and inhibits cell migration by targeting DLG2.
Zhuang RJ; Bai XX; Liu W
Cancer Biol Ther; 2019; 20(6):897-911. PubMed ID: 30862230
[TBL] [Abstract][Full Text] [Related]
13. Polo-like kinase 1 regulates cell proliferation and is targeted by miR-593* in esophageal cancer.
Ito T; Sato F; Kan T; Cheng Y; David S; Agarwal R; Paun BC; Jin Z; Olaru AV; Hamilton JP; Selaru FM; Yang J; Matsumura N; Shimizu K; Abraham JM; Shimada Y; Mori Y; Meltzer SJ
Int J Cancer; 2011 Nov; 129(9):2134-46. PubMed ID: 21170987
[TBL] [Abstract][Full Text] [Related]
14. MiR-100 resensitizes docetaxel-resistant human lung adenocarcinoma cells (SPC-A1) to docetaxel by targeting Plk1.
Feng B; Wang R; Chen LB
Cancer Lett; 2012 Apr; 317(2):184-91. PubMed ID: 22120675
[TBL] [Abstract][Full Text] [Related]
15. The histone demethylase KDM4B regulates peritoneal seeding of ovarian cancer.
Wilson C; Qiu L; Hong Y; Karnik T; Tadros G; Mau B; Ma T; Mu Y; New J; Louie RJ; Gunewardena S; Godwin AK; Tawfik OW; Chien J; Roby KF; Krieg AJ
Oncogene; 2017 May; 36(18):2565-2576. PubMed ID: 27869162
[TBL] [Abstract][Full Text] [Related]
16. Exosomal miR-940 maintains SRC-mediated oncogenic activity in cancer cells: a possible role for exosomal disposal of tumor suppressor miRNAs.
Rashed MH; Kanlikilicer P; Rodriguez-Aguayo C; Pichler M; Bayraktar R; Bayraktar E; Ivan C; Filant J; Silva A; Aslan B; Denizli M; Mitra R; Ozpolat B; Calin GA; Sood AK; Abd-Ellah MF; Helal GK; Berestein GL
Oncotarget; 2017 Mar; 8(12):20145-20164. PubMed ID: 28423620
[TBL] [Abstract][Full Text] [Related]
17. LINC00852 promotes the proliferation and invasion of ovarian cancer cells by competitively binding with miR-140-3p to regulate AGTR1 expression.
Qiao ZW; Jiang Y; Wang L; Wang L; Jiang J; Zhang JR; Mu P
BMC Cancer; 2021 Sep; 21(1):1004. PubMed ID: 34496800
[TBL] [Abstract][Full Text] [Related]
18. MiR-296-5p suppresses papillary thyroid carcinoma cell growth via targeting PLK1.
Zhou SL; Tang QL; Zhou SX; Ren RZ
Eur Rev Med Pharmacol Sci; 2019 Mar; 23(5):2084-2091. PubMed ID: 30915753
[TBL] [Abstract][Full Text] [Related]
19. MIEF2 over-expression promotes tumor growth and metastasis through reprogramming of glucose metabolism in ovarian cancer.
Zhao S; Zhang X; Shi Y; Cheng L; Song T; Wu B; Li J; Yang H
J Exp Clin Cancer Res; 2020 Dec; 39(1):286. PubMed ID: 33317572
[TBL] [Abstract][Full Text] [Related]
20. miR-296-5p suppresses cell viability by directly targeting PLK1 in non-small cell lung cancer.
Xu C; Li S; Chen T; Hu H; Ding C; Xu Z; Chen J; Liu Z; Lei Z; Zhang HT; Li C; Zhao J
Oncol Rep; 2016 Jan; 35(1):497-503. PubMed ID: 26549165
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
